BiotechTube

Alendronate 70mg weekly

ApprovedWithdrawn
1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Hyperparathyroidism

Conditions

Hyperparathyroidism

Trial Timeline

Jul 1, 2006 → Sep 1, 2009

NCT ID
NCT00359385

About Alendronate 70mg weekly

Alendronate 70mg weekly is a approved stage product being developed by Merck for Hyperparathyroidism. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00359385. Target conditions include Hyperparathyroidism.

What happened to similar drugs?

12 of 20 similar drugs in Hyperparathyroidism were approved

Approved (12) Terminated (1) Active (8)
✅Cinacalcet HClKyowa KirinApproved
✅Paricalcitol + CalcifediolAbbVieApproved
✅Paricalcitol + Darbepoetin alfaAbbVieApproved
✅AMG 073AmgenApproved
✅DenosumabAmgenApproved
✅Sensipar® + Vitamin DAmgenApproved
✅Traditional Vitamin D Therapy + CinacalcetAmgenApproved

Hype Score Breakdown

Clinical
20
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00359385ApprovedWithdrawn

Competing Products

20 competing products in Hyperparathyroidism

See all competitors
ProductCompanyStageHype Score
ASP7991 + Cinacalcet + PlaceboAstellas PharmaPhase 2
35
KHK7580 + KRN1493Kyowa KirinPhase 2/3
38
KHK7580Kyowa KirinPhase 1
29
KHK7580Kyowa KirinPhase 1/2
32
KHK7580Kyowa KirinPhase 3
40
KHK7580Kyowa KirinPhase 3
40
Cinacalcet HClKyowa KirinApproved
43
KHK7580 + Cinacalcet HydrochlorideKyowa KirinPhase 3
40
Placebo + KHK7580 low dose + KHK7580 middle dose + KHK7580 high dose + KRN1493Kyowa KirinPhase 2
35
Paricalcitol + CalcitriolAbbViePre-clinical
18
paricalcitol + maxacalcitol + paricalcitol placebo + maxacalcitol placeboAbbViePhase 3
40
Paricalcitol + CalcifediolAbbVieApproved
43
Paricalcitol + Darbepoetin alfaAbbVieApproved
43
EtelcalcetideAmgenPhase 3
40
Cinacalcet + PlaceboAmgenPhase 2
35
Cinacalcet + PlaceboAmgenPhase 3
40
Etelcalcetide + PlaceboAmgenPhase 1
29
Sensipar (Cinacalcet HCl)AmgenPhase 2
35
AMG 073 + PlaceboAmgenPhase 3
40
cinacalcetAmgenPhase 3
40